Position in JNJ
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$7,761,831
+$293,456 QoQ
Shares Held
30,562
+0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
3.34%
of 13F equity value
Holder Rank
#1,272
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Aull & Monroe Investment Management Corp holds $30,785,948 across 9 Drug Manufacturers - General names. JNJ ranks #2 (25.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,329 | $11,189,483 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
30,562 | $7,761,831 | |
| 3 | ABBV |
AbbVie Inc.
|
14,519 | $3,653,561 | |
| 4 | AMGN |
Amgen Inc
|
9,494 | $3,437,967 | |
| 5 | MRK |
Merck & Co., Inc.
|
18,386 | $2,362,601 | |
| 6 | PFE |
Pfizer Inc
|
38,318 | $922,697 | |
| 7 | NVS |
Novartis AG
|
3,771 | $590,991 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
9,214 | $530,910 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,761,831 | 30,562 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $7,468,375 | 30,553 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $6,223,193 | 30,071 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $5,556,481 | 29,967 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,454,648 | 29,163 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $5,251,986 | 31,669 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,679,903 | 32,360 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $5,481,193 | 33,822 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $5,044,127 | 34,511 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $5,903,018 | 37,316 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $5,872,420 | 37,466 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $5,890,465 | 37,820 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $6,455,114 | 38,999 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $6,046,395 | 39,009 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $7,053,457 | 39,929 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $6,654,959 | 40,738 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $7,231,402 | 40,738 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $7,259,872 | 40,963 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $7,041,754 | 41,163 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $6,740,687 | 41,738 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $6,878,224 | 41,752 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $6,894,811 | 41,952 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $6,738,382 | 42,816 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $6,464,816 | 43,423 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $6,099,544 | 43,373 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $6,028,439 | 45,973 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||